3tc Hiv published presentations and documents on DocSlides.
STRIIVING . Study. Design. Endpoints. Primary: pr...
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Endpoints. Primary: proportion of patients with HI...
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
The IATT Optimal Pediatric ARV List. . Presented...
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
implementation of Dolutegravir. Meireles MV. , Pa...
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Hall 11B, RAI Amsterdam. Uptake and Procurement of...
nd. 90: Child Friendly Formulations . Victor Mu...
Bob Harrington, MD. University of Washington . Pre...
LC-3 ero"-I3ns3tCut3tC-3cifl-"utna-3I-Ireᐄu...
Program. Improving Health. . . Promoting Wellness...
This program will include a discussion of off-lab...
Data . from other . cohorts and . regions to guid...
antiretroviral therapy for HIV-1:. a meta-analysi...
M. edications. in . Paediatrics. Dr Leon J. Levi...
Program. Improving Health. . . Promoting Wellness...
DRIVE-SHIFT. . Study. . Design. Endpoints. Prim...
Program. Improving Health. . . Promoting Wellness...
Medical Director, Specialty . Services. Southwest ...
and . Virologic. Outcomes . for Treatment-experie...
by Baseline NRTI Resistance . and Second-Line NRTI...
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Copyright © 2024 DocSlides. All Rights Reserved